Quantitative cardiac phosphoproteomics profiling during ischemia-reperfusion in an immature swine model.

Ischemia-reperfusion (I/R) results in altered metabolic and molecular responses, and phosphorylation is one of the most noted regulatory mechanisms mediating signaling mechanisms during physiological stresses. To expand our knowledge of the potential phosphoproteomic changes in the myocardium during I/R, we used Isobaric Tags for Relative and Absolute Quantitation-based analyses in left ventricular samples obtained from porcine hearts under control or I/R conditions. The data are available via ProteomeXchange with identifier PXD006066. We identified 1,896 phosphopeptides within left ventricular control and I/R porcine samples. Significant differential phosphorylation between control and I/R groups was discovered in 111 phosphopeptides from 86 proteins. Analysis of the phosphopeptides using Motif-x identified five motifs: (..R..S..), (..SP..), (..S.S..), (..S…S..), and (..S.T..). Semiquantitative immunoblots confirmed site location and directional changes in phosphorylation for phospholamban and pyruvate dehydrogenase E1, two proteins known to be altered by I/R and identified by this study. Novel phosphorylation sites associated with I/R were also identified. Functional characterization of the phosphopeptides identified by our methodology could expand our understanding of the signaling mechanisms involved during I/R damage in the heart as well as identify new areas to target therapeutic strategies.NEW & NOTEWORTHY We used Isobaric Tags for Relative and Absolute Quantitation technology to investigate the phosphoproteomic changes that occur in cardiac tissue under ischemia-reperfusion conditions. The results of this study provide an extensive catalog of phosphoproteins, both predicted and novel, associated with ischemia-reperfusion, thereby identifying new pathways for investigation.

[1]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[2]  Matthew W. Foster,et al.  Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure , 2014, PloS one.

[3]  J. Lupski,et al.  De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease , 2016, Human Genetics.

[4]  A. Mattiazzi,et al.  Phospholamban phosphorylation by CaMKII under pathophysiological conditions. , 2008, Frontiers in bioscience : a journal and virtual library.

[5]  J. Lord,et al.  Serine/threonine protein kinases and apoptosis. , 2000, Experimental cell research.

[6]  E. Krebs,et al.  Protein phosphorylation and signal transduction. , 1999, Pharmacology & therapeutics.

[7]  M. Chou,et al.  Using the scan‐x Web Site to Predict Protein Post‐Translational Modifications , 2011, Current protocols in bioinformatics.

[8]  J. Wrana TGF-β Receptors and Signalling Mechanisms , 1998, Mineral and Electrolyte Metabolism.

[9]  N. Isern,et al.  Pyruvate modifies metabolic flux and nutrient sensing during extracorporeal membrane oxygenation in an immature swine model. , 2015, American journal of physiology. Heart and circulatory physiology.

[10]  A. Alizadeh,et al.  Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies. , 2016, Life sciences.

[11]  J. Petrie,et al.  AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease , 2009, Clinical science.

[12]  E. Ciszak,et al.  Phosphorylation of serine 264 impedes active site accessibility in the E1 component of the human pyruvate dehydrogenase multienzyme complex. , 2007, Biochemistry.

[13]  P. Lyu,et al.  Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. , 2010, Free radical biology & medicine.

[14]  P. D. del Nido,et al.  Exogenous substrate preference of the post-ischaemic myocardium. , 1986, Cardiovascular research.

[15]  G. Lopaschuk,et al.  Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. , 1990, Circulation research.

[16]  J. Mccormack,et al.  Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. , 1996, Journal of molecular and cellular cardiology.

[17]  N. Isern,et al.  Triiodothyronine activates lactate oxidation without impairing fatty acid oxidation and improves weaning from extracorporeal membrane oxygenation. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[18]  R. Xiao,et al.  Dual site phospholamban phosphorylation and its physiological relevance in the heart. , 2002, Trends in cardiovascular medicine.

[19]  R. Hauer,et al.  Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. , 2009, Journal of molecular and cellular cardiology.

[20]  J. Ross,et al.  Dilated cardiomyopathy caused by tissue‐specific ablation of SC35 in the heart , 2004, The EMBO journal.

[21]  George M. Church,et al.  Predicting Protein Post-translational Modifications Using Meta-analysis of Proteome Scale Data Sets*S , 2009, Molecular & Cellular Proteomics.

[22]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[23]  R. Pearson,et al.  Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. , 1991, Methods in enzymology.

[24]  P. Grinwald Calcium uptake during post-ischemic reperfusion in the isolated rat heart: influence of extracellular sodium. , 1982, Journal of molecular and cellular cardiology.

[25]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[26]  Joseph A. Hill,et al.  Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. , 2010, The American journal of cardiology.

[27]  Joseph N. Brown,et al.  Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea , 2014, BMC Medical Genomics.

[28]  W. Hunter,et al.  Role of myofilaments and calcium handling in left ventricular relaxation. , 2000, Cardiology clinics.

[29]  C. Landry,et al.  Weak functional constraints on phosphoproteomes. , 2009, Trends in genetics : TIG.

[30]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[31]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[32]  P. Cohen,et al.  Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase , 1996, FEBS letters.

[33]  G. Heusch,et al.  The in-situ pig heart with regional ischemia/reperfusion - ready for translation. , 2011, Journal of molecular and cellular cardiology.

[34]  Melanie Y. White,et al.  The role of post‐translational modifications in acute and chronic cardiovascular disease , 2014, Proteomics. Clinical applications.

[35]  E. Schuman,et al.  Calcium-dependent dynamics of cadherin interactions at cell–cell junctions , 2011, Proceedings of the National Academy of Sciences.

[36]  J. R. Brown,et al.  Sites of phosphorylation on pyruvate dehydrogenase from bovine kidney and heart. , 1978, Biochemistry.

[37]  P. Hammer,et al.  Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. , 2006, The Annals of thoracic surgery.

[38]  S. Javadov,et al.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives. , 2014, Pharmacology & therapeutics.

[39]  Richard D. Smith,et al.  Phosphoproteomics Profiling of Human Skin Fibroblast Cells Reveals Pathways and Proteins Affected by Low Doses of Ionizing Radiation , 2010, PloS one.

[40]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[41]  Qingyu Xiao,et al.  Prioritizing functional phosphorylation sites based on multiple feature integration , 2016, Scientific Reports.

[42]  Ronald J. Moore,et al.  Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells , 2011, Proteomics.

[43]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..

[44]  J. H. Collins,et al.  Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. , 1986, The Journal of biological chemistry.

[45]  Rakesh Kumar,et al.  Structure, biochemistry, and biology of PAK kinases. , 2017, Gene.

[46]  Robert H. Anderson,et al.  Anatomy of the pig heart: comparisons with normal human cardiac structure , 1998, Journal of anatomy.

[47]  K. Kobayashi,et al.  Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts. , 1983, Journal of molecular and cellular cardiology.

[48]  M. Mocanu,et al.  Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. , 2005, American journal of physiology. Heart and circulatory physiology.

[49]  G. Angelini,et al.  Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[51]  P. Cohen,et al.  Substrate specificity of a multifunctional calmodulin-dependent protein kinase. , 1985, The Journal of biological chemistry.

[52]  R. London,et al.  Elevation in Cytosolic Free Calcium Concentration Early in Myocardial Ischemia in Perfused Rat Heart , 1987, Circulation research.

[53]  Y. Kagawa,et al.  Cloning and sequencing of cDNAs encoding alpha and beta subunits of human pyruvate dehydrogenase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Qiangzhen Yang,et al.  Tyrosine phosphorylation of dihydrolipoamide dehydrogenase as a potential cadmium target and its inhibitory role in regulating mouse sperm motility. , 2016, Toxicology.

[55]  F. Jordan,et al.  Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency. , 2016, Biochimica et biophysica acta.

[56]  A. Mattiazzi,et al.  Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr17 residue , 2004, Molecular and Cellular Biochemistry.

[57]  J. Hewitt,et al.  Re-evaluation of the Role of Calcium Homeostasis Endoplasmic Reticulum Protein (CHERP) in Cellular Calcium Signaling* , 2012, The Journal of Biological Chemistry.

[58]  Richard D. Smith,et al.  The influence of sample preparation and replicate analyses on HeLa Cell phosphoproteome coverage. , 2008, Journal of proteome research.

[59]  G. Dorn,et al.  SR and mitochondria: calcium cross-talk between kissing cousins. , 2013, Journal of molecular and cellular cardiology.

[60]  Andrew Emili,et al.  Comparative Proteomics Profiling of a Phospholamban Mutant Mouse Model of Dilated Cardiomyopathy Reveals Progressive Intracellular Stress Responses*S , 2008, Molecular & Cellular Proteomics.

[61]  Beñat Mallavia,et al.  Animal Models of Cardiovascular Diseases , 2011, Journal of biomedicine & biotechnology.

[62]  E. Kranias,et al.  Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants. , 2003, American journal of physiology. Heart and circulatory physiology.

[63]  M. Patel,et al.  Mutagenesis Studies of the Phosphorylation Sites of Recombinant Human Pyruvate Dehydrogenase. SITE-SPECIFIC REGULATION (*) , 1995, The Journal of Biological Chemistry.

[64]  L. Tretter,et al.  Stimulation of reactive oxygen species generation by disease-causing mutations of lipoamide dehydrogenase. , 2011, Human molecular genetics.

[65]  A. Shah,et al.  Contractile Function During Angiotensin-II Activation , 2015, Journal of the American College of Cardiology.

[66]  E. Kranias,et al.  Transgenic Approaches to Define the Functional Role of Dual Site Phospholamban Phosphorylation* , 1998, The Journal of Biological Chemistry.

[67]  G. Angelini,et al.  Cardiac Phosphoproteomics during Remote Ischemic Preconditioning: A Role for the Sarcomeric Z-Disk Proteins , 2014, BioMed research international.

[68]  K. Mitra,et al.  Novel Tyrosine-Phosphorylated Post-Pyruvate Metabolic Enzyme, Dihydrolipoamide Dehydrogenase, Involved in Capacitation of Hamster Spermatozoa1 , 2004, Biology of reproduction.

[69]  Hua Yang,et al.  Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation. , 2005, Journal of electrocardiology.

[70]  Pavel A. Pevzner,et al.  Universal database search tool for proteomics , 2014, Nature Communications.

[71]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[72]  S. Yuan Protein kinase signaling in the modulation of microvascular permeability. , 2002, Vascular pharmacology.

[73]  J. Colyer Phosphorylation States of Phospholambana , 1998 .

[74]  A. Sherry,et al.  Effects of dichloroacetate on mechanical recovery and oxidation of physiologic substrates after ischemia and reperfusion in the isolated heart. , 1998, Journal of cardiovascular pharmacology.

[75]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[76]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[77]  T. Patel,et al.  Regulation of pyruvate dehydrogenase complex in ischemic rat heart. , 1984, The American journal of physiology.

[78]  F. Clubb,et al.  Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.

[79]  M. Olson,et al.  Rho‐associated kinases in tumorigenesis: re‐considering ROCK inhibition for cancer therapy , 2012, EMBO reports.

[80]  Joshua N. Adkins,et al.  MASIC: A software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features , 2008, Comput. Biol. Chem..

[81]  Jin Han,et al.  Echinochrome A regulates phosphorylation of phospholamban Ser16 and Thr17 suppressing cardiac SERCA2A Ca2+ reuptake , 2014, Pflügers Archiv - European Journal of Physiology.

[82]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[83]  B. Giepmans,et al.  Gap junctional channels are parts of multiprotein complexes. , 2012, Biochimica et biophysica acta.

[84]  K. M. Popov,et al.  Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases. , 1997, Advances in enzyme regulation.

[85]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[86]  P. Sugden,et al.  Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. , 1979, The Biochemical journal.

[87]  K. Poh,et al.  Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition. , 2016, International journal of cardiology.

[88]  Ronald J. Moore,et al.  Combined pulsed-Q dissociation and electron transfer dissociation for identification and quantification of iTRAQ-labeled phosphopeptides. , 2009, Analytical chemistry.

[89]  S. Ikeda,et al.  Heart Failure–Associated Changes in RNA Splicing of Sarcomere Genes , 2010, Circulation. Cardiovascular genetics.

[90]  N. Isern,et al.  Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation. , 2013, American journal of physiology. Heart and circulatory physiology.

[91]  N. Isern,et al.  Triiodothyronine Facilitates Weaning From Extracorporeal Membrane Oxygenation by Improved Mitochondrial Substrate Utilization , 2014, Journal of the American Heart Association.

[92]  S. Sadayappan,et al.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease. , 2010, Journal of molecular and cellular cardiology.

[93]  David A. Kass,et al.  Tackling heart failure in the twenty-first century , 2008, Nature.

[94]  Ishtiaq Rehman,et al.  iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". , 2009, Journal of proteome research.

[95]  A. Mattiazzi,et al.  Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a β-adrenergic challenge , 2003, Molecular and Cellular Biochemistry.

[96]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[97]  Richard D. Smith,et al.  Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS. , 2016, Methods in molecular biology.

[98]  A. Emili,et al.  Using phosphoproteomics to monitor disregulated signaling networks in cardiac disease preceding heart failure. , 2013, Bioanalysis.

[99]  Wanqing Sun,et al.  Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[100]  Heiko Horn,et al.  In Vivo Phosphoproteomics Analysis Reveals the Cardiac Targets of β-Adrenergic Receptor Signaling , 2013, Science Signaling.

[101]  M. Goumans,et al.  The microRNA-15 family inhibits the TGFβ-pathway in the heart. , 2014, Cardiovascular research.

[102]  A. Panchenko,et al.  Phosphorylation in protein-protein binding: effect on stability and function. , 2011, Structure.

[103]  Ulrike Mende,et al.  Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.

[104]  K. Gunter,et al.  Calcium and mitochondria , 2004, FEBS letters.

[105]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[106]  R. Poston,et al.  Myocardial reperfusion injury: etiology, mechanisms, and therapies. , 2004, The journal of extra-corporeal technology.

[107]  L. Becker,et al.  Relation between glycolysis and calcium homeostasis in postischemic myocardium. , 1992, Circulation research.

[108]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[109]  P. Cohen,et al.  The regulation of protein function by multisite phosphorylation--a 25 year update. , 2000, Trends in biochemical sciences.

[110]  D. Yellon,et al.  Myocardial reperfusion injury. , 2007, The New England journal of medicine.

[111]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[112]  R. Hajjar,et al.  CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. , 2007, Cardiovascular research.